Cited by 296Viral-associated cancers and disordersIgG4-Related and Inflammatory DiseasesLymphadenopathy Diagnosis and Analysis

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV ‐8‐negative multicentric Castleman disease

Open access

Iwaki, Noriko, Fajgenbaum, David C., Nabel, Christopher S., Gion, Yuka, Kondo, Eisei, Kawano, Mitsuhiro, Masunari, Taro, Yoshida, Isao, Moro, Hiroshi, Nikkuni, Koji, Takai, Kazue, Matsue, Kosei, Kurosawa, Mitsutoshi, Hagihara, Masao, Saito, Akio, Okamoto, Masataka, Yokota, Kenji, Hiraiwa, Shinichiro, Nakamura, Naoya, Nakao, Shinji, Yoshino, Tadashi, Sato, Yasuharu·2016·American Journal of Hematology

DOI 10.1002/ajh.24242

Open this paper in CoChat — free account Open PDF

Abstract

Multicentric Castleman disease (MCD) describes a heterogeneous group of disorders involving systemic inflammation, characteristic lymph node histopathology, and multi‐organ dysfunction because of pathologic hypercytokinemia. Whereas Human Herpes Virus‐8 (HHV‐8) drives the hypercytokinemia in a cohort of immunocompromised patients, the etiology of HHV‐8‐negative MCD is idiopathic (iMCD). Recently, a limited series of iMCD cases in Japan sharing a constellation of clinical features, including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O) has been described as TAFRO syndrome. Herein, we report clinicopathological findings on 25 patients (14 males and 11 females; 23 Japanese‐born and two US‐born), the largest TAFRO syndrome case series, including the first report of cases from the USA. The median age of onset was 50 years old (range: 23–72). The frequency of each feature was as follows: thrombocytopenia (21/25), anasarca (24/25), fever (21/25), organomegaly (25/25), and reticulin fibrosis (13/16). These patients frequently demonstrated abdominal pain, elevated serum alkaline phosphatase levels, and acute kidney failure. Surprisingly, none of the cases demonstrated marked hypergammoglobulinemia, which is frequently reported in iMCD. Lymph node biopsies revealed atrophic germinal centers with enlarged nuclei of endothelial cells and proliferation of endothelial venules in interfollicular zone. 23 of 25 cases were treated initially with corticosteroids; 12 patients responded poorly and required further therapy. Three patients died during the observation period (median: 9 months) because of disease progression or infections. TAFRO syndrome is a unique subtype of iMCD that demonstrates characteristic clinicopathological findings. Further study to clarify prognosis, pathophysiology, and appropriate treatment is needed. Am. J. Hematol. 91:220–226, 2016. © 2015 Wiley Periodicals, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/ajh.24242

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
Kanda, Y. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.244 · Cited by 18,876
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
European consensus on grading bone marrow fibrosis and assessment of cellularity.
Thiele, J., Kvasnicka, H. M., Facchetti, F., Franco, V., van der Walt, J. D., & Orazi, A. (2005) · PubMed · Cited by 762
Interleukin-6 is a potent thrombopoietic factor in vivo in mice
Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., KARIYONE, S., Hirano, T., Kishimoto, T., Takatsuki, F., & Akiyama, Y. (1989) · Blood · doi:10.1182/blood.v74.4.1241.1241 · Cited by 431
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler, E., Boulanger, E., Galicier, L., Du, M., Dupin, N., Diss, T., Hamoudi, R., Daniel, M., Agbalika, F., Boshoff, C., et al. (2002) · Blood · doi:10.1182/blood.v99.7.2331 · Cited by 421
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.
Ishibashi, T., Kimura, H., Uchida, T., KARIYONE, S., Friese, P., & Burstein, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5953 · Cited by 406
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.
Frizzera, G., Peterson, B. A., Bayrd, E. D., & Goldman, A. I. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.9.1202 · Cited by 380
Surgery in Castleman's Disease
Talat, N., Belgaumkar, A. P., & Schulte, K. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318249dcdc · Cited by 358
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy
Fajgenbaum, D. C., van Rhee, F., & Nabel, C. S. (2014) · Blood · doi:10.1182/blood-2013-12-545087 · Cited by 336
Self-citation
An Interleukin‐6–Related Systemic Inflammatory Syndrome in Patients Co‐Infected with Kaposi Sarcoma–Associated Herpesvirus and HIV but without Multicentric Castleman Disease
Uldrick, T. S., Wang, V., O’Mahony, D., Aleman, K. O., Wyvill, K. M., Marshall, V. A., Steinberg, S. M., Pittaluga, S., Marić, I., Whitby, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/654798 · Cited by 304
A systemic lymphoproliferative disorder with morphologic features of Castlemanʼs disease
Frizzera, G., Massarelli, G., Banks, P. M., & Rosaí, J. (1983) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198304000-00001 · Cited by 283
POEMS syndrome: 2021 Update on diagnosis, risk‐stratification, and management
Dispenzieri, A. A. (2021) · American Journal of Hematology · doi:10.1002/ajh.26240 · Cited by 255
Fifty years of multicentric Castleman's disease
Waterston, A. M., & Bower, M. (2004) · Acta Oncologica · doi:10.1080/02841860410002752 · Cited by 205
Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities
Eddahri, F., Denanglaire, S., Bureau, F., Spolski, R. J., Leonard, W. J., Léo, O., & Andris, F. (2008) · Blood · doi:10.1182/blood-2008-04-154682 · Cited by 200
[Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly].
Takai, K., Nikkuni, K., Shibuya, H., & Hashidate, H. (2010) · PubMed · Cited by 181
Self-citation
POEMS syndrome: 2014 Update on diagnosis, risk‐stratification, and management
Dispenzieri, A. A. (2014) · American Journal of Hematology · doi:10.1002/ajh.23644 · Cited by 133
How I treat HIV-associated multicentric Castleman disease
Bower, M. (2010) · Blood · doi:10.1182/blood-2010-07-290213 · Cited by 132
Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients
Dao, L. N., Hanson, C. A., Dispenzieri, A. A., Morice, W. G., Kurtin, P. J., & Hoyer, J. D. (2011) · Blood · doi:10.1182/blood-2010-11-316935 · Cited by 125
HHV‐8 infection status of AIDS‐unrelated and AIDS‐associated multicentric Castleman's disease
Suda, T., Katano, H., Delsol, G., Kakiuchi, C., Nakamura, T., Shiota, M., Sata, T., Higashihara, M., & Mori, S. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01266.x · Cited by 124
How I treat POEMS syndrome
Dispenzieri, A. A. (2012) · Blood · doi:10.1182/blood-2012-03-378992 · Cited by 120
IL‐6 Triggers IL‐21 production by human CD4+ T cells to drive STAT3‐dependent plasma cell differentiation in B cells
Diehl, S. A., Schmidlin, H., Nagasawa, M., Blom, B., & Spits, H. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.17 · Cited by 119
Chromosome studies on some human tumors and tissues of normal origin, grown in vivo and in vitro at the Sloan-Kettering Institute
LEVAN, A. (1956) · Cancer · doi:10.1002/1097-0142(195607/08)9:4 · Cited by 107
Clinical Implications of Idiopathic Multicentric Castleman Disease Among Japanese: A Report of 28 Cases
Kojima, M., Nakamura, N., Tsukamoto, N., Otuski, Y., Shimizu, K., Itoh, H., Kobayashi, S., Kobayashi, H., Murase, T., Masawa, N., et al. (2008) · International Journal of Surgical Pathology · doi:10.1177/1066896908315812 · Cited by 104
Self-citation
Japanese Variant of Multicentric Castleman's Disease Associated With Serositis and Thrombocytopenia ^|^mdash; A Report of Two Cases: Is TAFRO Syndrome (Castleman- Kojima Disease) a Distinct Clinicopathological Entity?
Masaki, Y., Nakajima, A., Iwao, H. K., Kurose, N., Sato, T., Nakamura, T., Miki, M., Sakai, T., Kawanami, T., Sawaki, T., et al. (2013) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.53.79 · Cited by 92
Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
Inoue, M., Ankou, M., Jiang, H., Iwaki, Y., Hagihara, M., & Ota, Y. (2013) · Journal of Clinical and Experimental Hematopathology · doi:10.3960/jslrt.53.95 · Cited by 79
Self-citation
Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus
Chadburn, A., Cesarman, E., Nádor, R. G., Liu, Y. F., & Knowles, D. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970815)80:4 · Cited by 74
Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
Kawabata, H., Kotani, S., Matsumura, Y., Kondo, T., Katsurada, T., Haga, H., Kadowaki, N., & Takaori-Kondo, A. (2013) · Internal medicine · doi:10.2169/internalmedicine.52.9482 · Cited by 71
Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
Iwaki, N., Sato, Y., Takata, K., Kondo, E., Ohno, K., Takeuchi, M., Orita, Y., Nakao, S., & Yoshino, T. (2013) · Journal of Clinical and Experimental Hematopathology · doi:10.3960/jslrt.53.87 · Cited by 66
Self-citation
Thrombocytopenia with Reticulin Fibrosis Accompanied by Fever, Anasarca and Hepatosplenomegaly : A Clinical Report of Five Cases
Takai, K., Nikkuni, K., Momoi, A., Nagai, K., Igarashi, N., & Saeki, T. (2013) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.53.63 · Cited by 61
Self-citation
Systemic Lupus Erythematosus (SLE) lymphadenopathy presenting with histopathologic features of castleman Disease: A Clinicopathologic Study of Five Cases
Kojima, M., Nakamura, S., Itoh, H., Yoshida, K., Asano, S., Yamane, N., Komatsumoto, S., Ban, S., Joshita, T., & Suchi, T. (1997) · Pathology - Research and Practice · doi:10.1016/s0344-0338(97)80015-5 · Cited by 54
Eruptive Cherry Hemangiomatosis Associated With Multicentric Castleman Disease
Fajgenbaum, D. C., Rosenbach, M. A., van Rhee, F., Nasir, A., & Reutter, J. C. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.1552 · Cited by 51
Self-citation
Bone Marrow Findings in HIV-Positive Patients With Kaposi Sarcoma Herpesvirus–Associated Multicentric Castleman Disease
Venkataraman, G., Uldrick, T. S., Aleman, K. O., O’Mahony, D., Karcher, D. S., Steinberg, S. M., Raffeld, M. A., Marshall, V. A., Whitby, D., Little, R. F., et al. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpkgf7u8awqbvg · Cited by 32
A Case of Multicentric Castleman's Disease of Mixed-Type, which Showed Constellation of Symptoms, i.e., Thrombocytopenia, Anasarca, Anemia, Fever, Myelofibrosis, and Lymphadenopathy
Awano, N., Inomata, M., Sonoda, Y., Kondoh, K., Ono, R., Moriya, A., Ando, T., Kumasaka, T., Takemura, T., Takeuchi, K., et al. (2013) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.53.101 · Cited by 22
Bone Marrow Findings in Multicentric Castleman Disease in HIV-negative Patients
Kreft, A., Weber, A., Springer, E., Heß, G., & Kirkpatrick, C. J. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213382.40289.68 · Cited by 20
First European Case of TAFRO Syndrome Associated with Sjogren Disease
Abdo, L. A. (2014) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20140206.12 · Cited by 19
HHV-8-Negative, Idiopathic Multicentric Castleman Disease (iMCD): A Description of Clinical Features and Therapeutic Options through a Systematic Literature Review
Fajgenbaum, D. C., Liu, A. Y., Ruth, J. R., Nabel, C., Finkelman, B. S., Kurzrock, R., van Rhee, F., & Rubenstein, A. H. (2014) · Blood · doi:10.1182/blood.v124.21.4861.4861 · Cited by 10
Self-citation
[Human herpesvirus 8 and associated diseases: Kaposi's sarcoma, body cavity based lymphoma and multicentric Castleman disease: clinical and molecular epidemiology].
Antoine Gessain, A. (1998) · PubMed · Cited by 9
Effect of local radiotherapy on the level of EBV-associated membrane-reactive antibodies in the sera of patients with certain malignant tumors
Einhorn, N. (1972) · Cancer · doi:10.1002/1097-0142(197203)29:3 · Cited by 4

Flagged first, then by citations

1 of the 39 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Gessain A., 1997, [Human herpesvirus 8 and associated diseases: Kaposi's sarcoma, body cavity based, Bull Acad Natl Med, 181, 1023
Takai K, 2010, Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural, Rinsho Ketsueki, 51, 320

Sorted by citations

Cytokine storm
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Self-citation
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
Fajgenbaum, D., Uldrick, T., Bagg, A., Frank, D. M., Wu, D., Srkalović, G., Simpson, D., Liu, A. Y., Menke, D., Chandrakasan, S., et al. (2017) · Blood · doi:10.1182/blood-2016-10-746933 · Cited by 601
Self-citation
Overview of Castleman disease
Dispenzieri, A., & Fajgenbaum, D. C. (2020) · Blood · doi:10.1182/blood.2019000931 · Cited by 487
Self-citation
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
Rhee, F. V., Voorhees, P., Dispenzieri, A., Fosså, A., Srkalović, G., Ide, M., Munshi, N., Schey, S., Streetly, M., Pierson, S., et al. (2018) · Blood · doi:10.1182/blood-2018-07-862334 · Cited by 387
Self-citation
Idiopathic multicentric Castleman's disease: a systematic literature review
Liu, A. Y., Nabel, C. S., Finkelman, B. S., Ruth, J. R., Kurzrock, R., van Rhee, F., Krymskaya, V. P., Kelleher, D. P., Rubenstein, A. H., & Fajgenbaum, D. C. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)00006-5 · Cited by 331
Self-citation

See all 296

Authors: Iwaki, N., Fajgenbaum, D. C., Nabel, C. S., Gion, Y., Kondo, E., Kawano, M., Masunari, T., Yoshida, I., Moro, H., Nikkuni, K., Takai, K., Matsue, K., Kurosawa, M., Hagihara, M., Saito, A., Okamoto, M., Yokota, K., Hiraiwa, S., Nakamura, N., Nakao, S., Yoshino, T., & Sato, Y.
Affiliations: Kanazawa University (JP)
University of Pennsylvania (US)
Okayama University (JP)
Kanazawa University Hospital (JP)
Chugoku Central Hospital (JP)
Shikoku Cancer Center (JP)
Niigata University (JP)
Niigata City General Hospital (JP)
Kameda Medical Center (JP)
Sapporo National Hospital (JP)
Eiju General Hospital (JP)
National Hospital Organization (JP)
Fujita Health University (JP)
Tokai University (JP)
Corresponding author: Sato, Yasuharu
ORCID: Fajgenbaum, David C.
Nabel, Christopher S.
Gion, Yuka
Kondo, Eisei
Kawano, Mitsuhiro
Masunari, Taro
Yoshida, Isao
Moro, Hiroshi
Matsue, Kosei
Hagihara, Masao
Yokota, Kenji
Hiraiwa, Shinichiro
Nakamura, Naoya
Nakao, Shinji
Sato, Yasuharu
Venue: American Journal of Hematology
Publisher: Wiley
Published: 2016-01-22
Volume: 91
Issue: 2
Pages: 220-226
ISSN: 0361-8609 (ISSN-L)
1096-8652
DOI: 10.1002/ajh.24242
OpenAlex: W2179940598
Cited by: 296
References: 39
Citations by year: 2026: 28 · 2025: 30 · 2024: 30 · 2023: 19 · 2022: 31 · 2021: 29 · 2020: 34 · 2019: 23 · 2018: 34 · 2017: 30 · 2016: 7
FWCI: 10.48
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: American Journal of Hematology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphadenopathy Diagnosis and Analysis
Keywords: TAFRO syndrome, multicentric Castleman disease, idiopathic multicentric Castleman disease, thrombocytopenia, anasarca, fever, reticulin fibrosis, organomegaly, cytokine storm, lymph node histopathology, endothelial cell proliferation, corticosteroid therapy, acute kidney injury, hypergammaglobulinemia
MeSH terms: Adult, Aged, Female, Castleman Disease, Humans, Lymph Nodes, Male, Middle Aged, Plasma Cells, Platelet Count, Syndrome, Thrombocytopenia, Herpesvirus 8, Human, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV ‐8‐negative multicentric Castleman disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks